SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-261326
Filing Date
2020-10-01
Accepted
2020-10-01 16:22:33
Documents
13
Period of Report
2020-10-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d22531d8k.htm   iXBRL 8-K 33270
  Complete submission text file 0001193125-20-261326.txt   211375

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA jnj-20201001.xsd EX-101.SCH 5148
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE jnj-20201001_def.xml EX-101.DEF 14813
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jnj-20201001_lab.xml EX-101.LAB 24977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jnj-20201001_pre.xml EX-101.PRE 15976
6 EXTRACTED XBRL INSTANCE DOCUMENT d22531d8k_htm.xml XML 9515
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 201216174
SIC: 2834 Pharmaceutical Preparations